Drug Development Advisory Board

The Drug Development Advisory Board (DAB) at Simbec-Orion was established to offer our clients additional support and guidance in their drug development journey. All members of our DAB are independent of Simbec-Orion, and each are hand-picked as experts in their chosen fields.

These respected scientists utilise their individual areas of expertise to offer specialist insights to our clients, including supporting with aspects of study design and protocol development, regulatory advice, and interpretation of emerging study data.

Our DAB members include leading authorities in our core therapeutic areas of oncology and rare disease. Other individuals bring their extensive experience across all stages of the pharmaceutical development process, including non-clinical, first in human, drug metabolism, and pharmacokinetics.

Drug Development Advisory Board

Pierre Attali

Member of Drug Development Advisory Board

View Profile

Simon Hutchings

Member of Drug Development Advisory Board

View Profile

Art Gertel

Member of Drug Development Advisory Board

View Profile

Jörn Klinger

Member of Drug Development Advisory Board

View Profile

Marco Schmidt

Member of Drug Development Advisory Board

View Profile

Alan Philips

Drug Development Advisory Board

View Profile

Geoff Kitson

Vaccines & Infectious Disease Expert

View Profile

Kirsty Wydenbach

Regulatory & Pharmaceutical Medicine Expert

View Profile

David Jones

Pharmaco-toxicology Expert

View Profile

Sarah Blagden

Oncology Scientific Advisory Board

View Profile

Samson Fung

Oncology Scientific Advisory Board

View Profile

Ahmad Awada

Oncology Scientific Advisory Board

View Profile

Carlos Camozzi

Chair, Rare & Orphan Scientific Advisory Board

View Profile

Alain Thibault

Chair, Oncology Scientific Advisory Board

View Profile

Navigating the Regulatory Journey from Nonclinical to Early Phase Clinical Trials

Two-part webinar series: Two of our Scientific Advisory Board members presented a webinar series examining the transition from nonclinical to early clinical from a regulatory perspective and highlighting the key areas where your program can benefit from some forward thinking and planning for your next steps.

Got a question?
Get in Touch or Submit an RFI/RFP

Our team is on hand to answer any questions you might have relating to the work we do at Simbec-Orion. Just fill in the form below, making sure to tick the boxes that apply, and we’ll respond as quickly as we can.

Looking to volunteer for a clinical trial?

Visit our dedicated volunteer website here, or email [email protected]

Follow us on Social Media

Name(Required)
Opt In Emails